RE: Talk of bagging is nonsense5 Oct 2020 23:11
The objective of the project is to develop a portable test. This is what makes this investment exciting!
Market cap of <£13M for a 90 second covid 19 test with POC nearly validated!! (No need to ramp!)
From: https://www.londonstockexchange.com/news-article/BRH/final-results/14639862
The Company (Paraytec) has commenced a programme with University of Sheffield to develop a rapid test for the pandemic pathogen, COVID-19. The test involves the deployment of a DNA aptamer - a short, single-stranded DNA molecule that adopts a shape that is complementary to that of the virus surface protein. By coating a test surface with millions of copies of the aptamer molecule, our capture module can trap Covid-19 virus particles from a swab sample, as they flow over the test surface. Trapped viruses are then instantaneously coated with the signal generation module, a synthetic chimaeric protein, that both recognises the viral surface as well as being highly fluorescent. The resultant fluorescent signal is measured by the detection module using a version of Paraytec's patented Actipix area imaging technology configured for fluorescence detection.
In this project, Paraytec is working with Professor Carl Smythe's group at the University of Sheffield - which has expertise in the field of synthetic bio-molecular sensors. Formerly Academic Director of the Sheffield Cancer Centre, Prof Smythe's research is focused on cellular quality control systems monitoring chromosomal DNA. With 35 years' research experience, he has, together with collaborators in academia and industry, developed a wide range of sensor systems with applications in disease testing.
The objective of the project is to develop a portable test, which can generate a result in a matter of minutes from a swab provided at the test location and which requires no specialist skills for its operation. If successful, it could be used in airports, transport hubs, large workplaces and similar settings, where rapid screening of large numbers of people for presence of COVID-19 or any future emerging pandemic is required.
Test, test, test